NOFSA statement on generic bisphosphonates.
de Jongh
J N
JN
D019386:Alendronate / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004164:Diphosphonates / Q000493:pharmacokinetics* / Q000627:therapeutic use; D017277:Drug Approval; D006801:Humans; D010024:Osteoporosis / Q000517:prevention & control; D013019:South Africa; D013810:Therapeutic Equivalency
D004164:Diphosphonates; D019386:Alendronate